-
761“…Leishmaniasis is a protozoan disease caused by the parasite Leishmania. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
762por de Almeida, Marcos, Zheng, Yueli, Nascimento, Fernanda S., Bishop, Henry, Cama, Vitaliano A., Batra, Dhwani, Unoarumhi, Yvette, Afghan, Abaseen K., Shi, Vivian Y., LeBoit, Philip E., Liu, Eugene W., Donovan, Fariba M.“…We investigated an autochthonous case of cutaneous leishmaniasis caused by a genetically different Leishmania sp. in a patient in Arizona, USA. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
763por Akuffo, Richard, Sanchez, Carmen, Chicharro, Carmen, Carrillo, Eugenia, Attram, Naiki, Mosore, Mba-Tihssommah, Yeboah, Clara, Kotey, Nana Konama, Boakye, Daniel, Ruiz-Postigo, Jose-Antonio, Moreno, Javier, Wilson, Michael, Sarfo, Bismark, Anto, Francis“…BACKGROUND: Cutaneous leishmaniasis (CL) is the most common type of leishmaniasis, a neglected tropical disease caused by parasites of the genus Leishmania. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
764por Hailu, Workagegnehu, Mohamed, Rezika, Fikre, Helina, Atnafu, Saba, Tadesse, Azeb, Diro, Ermias, van Grienvsen, Johan“…BACKGROUND: Visceral Leishmaniasis (VL) is a neglected tropical disease endemic to several countries including Ethiopia. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
765por Passero, Luiz Felipe D., Brunelli, Erika dos Santos, Sauini, Thamara, Amorim Pavani, Thais Fernanda, Jesus, Jéssica Adriana, Rodrigues, Eliana“…Leishmaniasis is a neglected tropical disease that affects people living in tropical and subtropical areas of the world. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
766“…The Th1 (IFN-γ) and Th2 (IL-4) cytokines, which induce classically-activated (M1) or alternatively-activated (M2) macrophages, underlie resistance versus susceptibility to leishmaniasis. While macrophage phenotypes have been well discussed, new developments addressed the monocyte functional phenotypes in Leishmania infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
767
-
768
-
769“…Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishmaniasis. Despite limited therapies for visceral leishmaniasis and emerging drug resistance, a proper review on the action of paromomycin for kala-azar is lacking. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
770por Idrissi, Houda, Hakkour, Maryam, Duchateau, Luc, Zanatta, Renato, Kachani, Malika, Azrib, Rahma, Daminet, Sylvie, Kichou, Faouzi, El Asatey, Sabrine, Tazi, Noureddine, Sahibi, Hamid, El Hamiani Khatat, Sarah“…Canine leishmaniasis (CanL) is a zoonotic vector-borne disease that is endemic in the Mediterranean Basin including Morocco. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
771por Sampaio, Raimunda Nonata Ribeiro, Ferreira, Marina Freitas, Martins, Sofia Sales, Motta, Jorgeth de Oliveira Carneiro da“…Diffuse cutaneous leishmaniasis is a rare universal disease associated with an inadequate host cell immune response, caused by different species: infantum, aethiopica, major, mexicana, and others, which presents the challenge of a poor therapeutic response. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
772por Volpedo, Greta, Pacheco-Fernandez, Thalia, Bhattacharya, Parna, Oljuskin, Timur, Dey, Ranadhir, Gannavaram, Sreenivas, Satoskar, Abhay R., Nakhasi, Hira L.“…Leishmaniasis is endemic to the tropical and subtropical regions of the world and is transmitted by the bite of an infected sand fly. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
773por Zijlstra, Eduard E.“…Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the individual patient. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
774por Pikoulas, Antonis, Piperaki, Evangelia-Theophano, Spanakos, Gregory, Kallianos, Anastasios, Mparmparousi, Despoina, Rentziou, Gianna, Trakada, Georgia“…We present a case of coinfection with COVI19 and visceral leishmaniasis and discuss recent reports regarding coexistence of SARS-CoV2 and Leishmania spp. to date.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
775“…Despite being endemic in more than 80 countries and its being the cause of high morbidity and mortality, leishmaniasis remains a neglected tropical disease. Chemotherapy is the frontline treatment, but drugs in current use suffer from toxic side effects, difficulties in administration and extended treatment times — moreover, resistance is emerging. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
776por Maristany Bosch, Marta, Cuervo, Guillermo, Matas Martín, Elisabeth, Veciana de las Heras, Misericordia, Pedro Pérez, Jordi, Martínez Yélamos, Sergio, Sabé Fernández, Nuria“…INTRODUCTION: Although pentavalent antimonials are no longer considered the first-line therapy for visceral leishmaniasis in the developed world, they are still used in certain geographical areas and in refractory cases. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
777
-
778“…Cutaneous leishmaniasis (CL) is the most prevalent clinical form of leishmaniasis and is caused by vector‐borne protozoan parasite. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
779
-
780